H. Kröning - Concepedia

Author

H. Kröning

Also Known As

Christoph Bremer, H Kröning, H. KRÖNING, H. Kroning, H. Kröning, HENDRIK KRÖNING, Hendrik Kröning, Jin Tung Liang, Thomas Helmberger, Winston Liauw

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Praxis für Hämatologie und Onkologie Otto-von-Guericke University Magdeburg Klinikum Magdeburg Roche (Switzerland)University Hospital Magdeburg

About

H. Kröning is an author at Praxis für Hämatologie und Onkologie specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	873
2	Health Sciences	1	1	12
3	Natural Sciences	1	1	41
4	Biochemistry	1	1	41
5	Biostatistics	1	1	29

H. Kröning

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer Chris Twelves, A. Wong, Marek P. Nowacki, New England Journal of Medicine	2005	1.2K
EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Alberto Sobrero, Joan Maurel, Louis Fehrenbacher, Journal of Clinical Oncology	2008	945
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer Guy A. Van Hazel, Volker Heinemann, Navesh Sharma, Journal of Clinical Oncology	2016	339
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning, Annals of Oncology Venous DiseaseOncologyVenous ThrombosisCentral Venous CathetersPatient Safety	2005	219
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer Karsten Ridwelski, T. Gebauer, J. Fahlke, Annals of Oncology Combination ChemotherapyGastrointestinal OncologyMedicineGastroenterologySurgery	2001	167
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings Stefan Kubicka, Richard Greil, Thierry André, Annals of Oncology Gastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2013	101
Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells. Michael Täger, H. Kröning, U Thiel, PubMed	1997	82
Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer C. Jehn, L. Böning, H. Kröning, British Journal of Cancer	2012	77
Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial Jim Cassidy, Werner Scheithauer, J. McKendrick, Journal of Clinical Oncology Surgical OncologyCancer ManagementPharmacotherapySurgeryGynecology Oncology	2004	74
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial Stefan Boeck, K. Weigang-Köhler, Martin Fuchs, Annals of Oncology Surgical OncologyPancreatic CancerGemcitabine FailureGastrointestinal OncologyMedicine	2007	68

Page 1